These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10988262)

  • 1. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy.
    Kozàkovà M; Galetta F; Gregorini L; Bigalli G; Franzoni F; Giusti C; Palombo C
    Hypertension; 2000 Sep; 36(3):343-9. PubMed ID: 10988262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography.
    Kozàkovà M; Palombo C; Pratali L; Pittella G; Galetta F; L'Abbate A
    Hypertension; 1997 Feb; 29(2):551-9. PubMed ID: 9040437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study.
    Hildick-Smith DJ; Johnson PJ; Wisbey CR; Winter EM; Shapiro LM
    Heart; 2000 Oct; 84(4):383-9. PubMed ID: 10995406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal doppler echocardiography.
    Hamouda MS; Kassem HK; Salama M; El Masry M; Shaaban N; Sadek E; Khandheria BK; Seward JB; Elhendy A
    Am J Cardiol; 2000 Aug; 86(3):305-8. PubMed ID: 10922438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicardial coronary arteries are not adequately sized in hypertensive patients.
    Nitenberg A; Antony I
    J Am Coll Cardiol; 1996 Jan; 27(1):115-23. PubMed ID: 8522684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
    Kjaer A; Meyer C; Wachtell K; Olsen MH; Ibsen H; Opie L; Holm S; Hesse B
    Am J Cardiol; 2005 Dec; 96(12):1692-8. PubMed ID: 16360359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.
    Xiaozhen H; Yun Z; Mei Z; Yu S
    Blood Press; 2010 Feb; 19(1):40-7. PubMed ID: 20001392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy.
    Gimelli A; Schneider-Eicke J; Neglia D; Sambuceti G; Giorgetti A; Bigalli G; Parodi G; Pedrinelli R; Parodi O
    J Am Coll Cardiol; 1998 Feb; 31(2):366-73. PubMed ID: 9462581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In patients with hypertensive left ventricular hypertrophy and coronary heart disease, coronary flow reserve is similarly impaired.
    Chen D; Lin J; Chen J
    Chin Med Sci J; 1995 Sep; 10(3):151-7. PubMed ID: 8580484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients.
    Palombo C; Kozakova M; Magagna A; Bigalli G; Morizzo C; Ghiadoni L; Virdis A; Emdin M; Taddei S; L'Abbate A; Salvetti A
    J Hypertens; 2000 Apr; 18(4):453-9. PubMed ID: 10779097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can pathological left ventricular hypertrophy in arterial hypertension be distinguished from physiological hypertrophy caused by sports?].
    Schannwell CM; Marx R; Plehn G; Perings C; Leschke M; Strauer BE
    Dtsch Med Wochenschr; 2001 Mar; 126(10):263-7. PubMed ID: 11285760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced left ventricular performance in endurance trained older men.
    Seals DR; Hagberg JM; Spina RJ; Rogers MA; Schechtman KB; Ehsani AA
    Circulation; 1994 Jan; 89(1):198-205. PubMed ID: 8281647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy.
    Antony I; Nitenberg A; Foult JM; Aptecar E
    J Am Coll Cardiol; 1993 Aug; 22(2):514-20. PubMed ID: 8335823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of coronary reserve by transoesophageal Doppler echocardiography. Direct comparison between different modalities of dipyridamole and adenosine administration.
    Kozàkovà M; Palombo C; Pratali L; Bigalli G; Marzilli M; Distante A; L'Abbate A
    Eur Heart J; 1997 Mar; 18(3):514-23. PubMed ID: 9076391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
    Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
    Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary flow velocity reserve is diminished in hypertensive left ventricular hypertrophy.
    Nemes A; Neu K; Forster T; Kovacs Z; Csanady M
    Kardiol Pol; 2005 Jan; 62(1):1-5. PubMed ID: 15815773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microcirculation into different models of left ventricular hypertrophy-hypertensive and athlete's heart: a contrast echocardiographic study.
    Di Bello V; Giorgi D; Pedrinelli R; Talini E; Palagi C; Nardi C; Dell'Omo G; Delle Donne MG; Paterni M; Mariani M
    J Hum Hypertens; 2003 Apr; 17(4):253-63. PubMed ID: 12692570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.